IPO Preview: Biohaven Pharmaceuticals

Biohaven Pharmaceuticals expects to raise $112.6 million in its upcoming IPO ($130.1 million if the underwriters exercise their option to purchase additional shares).
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.